Rother T, Neugebauer A, Mende M, Kolb H J, Hagendorff A, Pfeiffer D
Abteilung für Kardiologie und Angiologie, Medizinische Universitätsklinik und Poliklinik I, Leipzig.
Z Kardiol. 2000 Apr;89(4):307-15. doi: 10.1007/s003920050490.
A fractional flow reserve (FFRmyo) < 0.75 is a well validated parameter for significance of coronary stenoses in cases of normal myocardial function. We used the FFRmyo limit in patients with impaired myocardial perfusion by myocardial infarction and/or hypertension for intermediate stenoses of the LAD for decision to PTCA and checked the indication by clinical follow-up.
In 20 pts (5 women) with chest pain and visual 50 D% LAD stenoses, the FFRmyo was obtained by using a RADI-Pressure-Wire, the CFR by a densitometric technique (HODGSON), and the geometry of stenosis (minimal lumen diameter and diameter stenosis) by quantitative coronary angiography (QCA). EF and the kinetics of the anterolateral wall (expressed as radial shortening fraction) were measured by laevography.
The mean age of our 20 pts. was 59.4 years: 13 of the pts. (65%) had a history of hypertension, 9 (45%) pts. a history of myocardial infarction. The mean diameter stenosis was 50.8%. The mean value of CFR was 2.9. The FFRmyo ranged from 0.66 to 0.90, the mean value was 0.78. The 12 pts. with FFRmyo > or = 0.75 (60%, group A) were treated with the usual anti-anginal medications. A PTCA was performed only in patients with FFRmyo < 0.75 (N = 8 (40%), group B). Except for one pt. with instent restenosis, in the 7 pts. with denovo stenoses stent implantation was performed. Significant differences between the groups A and B were seen only for the total number of myocardial infarctions (8/12 vs. 1/8) and diameter stenosis (48.5% vs. 54.3%). All lesions of group B had a diameter stenosis of 50% or higher. CFR correlated significantly with the radial shortening fraction (r = 0.75), minimal lumen diameter (r = -0.51) and diameter stenosis (r = -0.46). FFRmyo correlated with diameter stenosis (r = -0.47) only. All pts. treated with PTCA were primarily free of pain or reduced angina at least 1 CCS stage; only one developed an angina due to a restenosis (74 D%) 2 months after PTCA and stent implantation. The pts. of group A did not get worse, nor were they readmitted within 6 to 13 months after catheterization.
Pts. with 50 D% stenoses, impaired myocardial perfusion and FFRmyo < 0.75 had a good long-term benefit concerning clinical and angiographic result. No pts. with FFRmyo < 0.75 had a D% lower than 50; therefore, the PTCA of intermediate stenoses without quantification must be avoided. CFR is not helpful for a decision to PTCA in such cases, because a normal value of CFR is relevant only.
对于心肌功能正常的病例,冠状动脉狭窄的意义而言,心肌血流储备分数(FFRmyo)<0.75是一个经过充分验证的参数。我们将FFRmyo限值用于因心肌梗死和/或高血压导致心肌灌注受损的患者,针对左前降支(LAD)的中度狭窄决定是否进行经皮冠状动脉腔内血管成形术(PTCA),并通过临床随访检查该指征。
在20例(5名女性)有胸痛且造影显示LAD狭窄50%的患者中,使用RADI压力导丝获得FFRmyo,通过密度测定技术(霍奇森法)获得冠脉血流储备(CFR),通过定量冠状动脉造影(QCA)获得狭窄的几何形态(最小管腔直径和直径狭窄率)。通过左心室造影测量射血分数(EF)和前侧壁的运动(以径向缩短分数表示)。
我们这20例患者的平均年龄为59.4岁:其中13例(65%)有高血压病史,9例(45%)有心肌梗死病史。平均直径狭窄率为50.8%。CFR的平均值为2.9。FFRmyo范围为0.66至0.90,平均值为0.78。12例FFRmyo≥0.75的患者(60%,A组)接受常规抗心绞痛药物治疗。仅在FFRmyo<0.75的患者中进行PTCA(N = 8例(40%),B组)。除1例支架内再狭窄患者外,7例新发狭窄患者均进行了支架植入。A组和B组之间仅在心肌梗死总数(8/12 vs. 1/8)和直径狭窄率(48.5% vs. 54.3%)方面存在显著差异。B组所有病变的直径狭窄率均为50%或更高。CFR与径向缩短分数(r = 0.75)、最小管腔直径(r = -0.51)和直径狭窄率(r = -0.46)显著相关。FFRmyo仅与直径狭窄率(r = -0.47)相关。所有接受PTCA治疗的患者最初至少减轻1个加拿大心血管学会(CCS)心绞痛分级阶段的疼痛或减轻心绞痛症状;仅1例在PTCA和支架植入后2个月因再狭窄(74%)出现心绞痛。A组患者在6至13个月的导管插入术后病情未恶化,也未再次入院。
对于狭窄50%、心肌灌注受损且FFRmyo<0.75的患者,在临床和血管造影结果方面有良好的长期获益。没有FFRmyo<0.75的患者狭窄率低于50%;因此,必须避免对未进行定量的中度狭窄进行PTCA。在此类情况下,CFR无助于决定是否进行PTCA,因为正常的CFR值才具有相关性。